Trade Theravance Biopharma, Inc. - TBPH CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 10.12 |
| Open | 10.19 |
| 1-Year Change | 7.26% |
| Day's Range | 10.14 - 10.37 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 10.18 | 0.46 | 4.73% | 9.72 | 10.23 | 9.71 |
| Jul 24, 2024 | 9.96 | 0.16 | 1.63% | 9.80 | 10.16 | 9.72 |
| Jul 23, 2024 | 10.03 | -0.10 | -0.99% | 10.13 | 10.22 | 9.93 |
| Jul 22, 2024 | 10.19 | 0.66 | 6.93% | 9.53 | 10.30 | 9.52 |
| Jul 19, 2024 | 9.52 | -0.10 | -1.04% | 9.62 | 9.71 | 9.42 |
| Jul 18, 2024 | 9.65 | 0.04 | 0.42% | 9.61 | 9.95 | 9.48 |
| Jul 17, 2024 | 9.87 | 0.33 | 3.46% | 9.54 | 9.97 | 9.54 |
| Jul 16, 2024 | 9.97 | 0.24 | 2.47% | 9.73 | 10.16 | 9.73 |
| Jul 15, 2024 | 9.85 | 0.50 | 5.35% | 9.35 | 9.94 | 9.35 |
| Jul 12, 2024 | 9.29 | 0.06 | 0.65% | 9.23 | 9.71 | 9.10 |
| Jul 11, 2024 | 9.30 | 0.50 | 5.68% | 8.80 | 9.49 | 8.71 |
| Jul 10, 2024 | 8.77 | -0.06 | -0.68% | 8.83 | 9.01 | 8.69 |
| Jul 9, 2024 | 8.89 | 0.20 | 2.30% | 8.69 | 8.94 | 8.55 |
| Jul 8, 2024 | 8.79 | 0.05 | 0.57% | 8.74 | 8.83 | 8.61 |
| Jul 5, 2024 | 8.71 | 0.35 | 4.19% | 8.36 | 8.76 | 8.24 |
| Jul 3, 2024 | 8.47 | 0.23 | 2.79% | 8.24 | 8.48 | 8.09 |
| Jul 2, 2024 | 8.30 | -0.10 | -1.19% | 8.40 | 8.46 | 8.28 |
| Jul 1, 2024 | 8.46 | 0.26 | 3.17% | 8.20 | 8.57 | 8.19 |
| Jun 28, 2024 | 8.43 | 0.14 | 1.69% | 8.29 | 8.46 | 8.26 |
| Jun 27, 2024 | 8.27 | 0.00 | 0.00% | 8.27 | 8.38 | 8.25 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Theravance Biopharma, Inc. Company profile
About Theravance Biopharma Inc
Theravance Biopharma, Inc. is a diversified biopharmaceutical company, which is primarily focused on the discovery, development and commercialization of organ-selective medicines. The Company develops transformational medicines to improve the lives of patients suffering from serious illnesses. The Company's research is focused in the areas of inflammation and immunology. It applies organ-selective knowledge to biologically compelling targets to discover and develop medicines, which are designed to treat underserved localized diseases and to limit systemic exposure. The Company is developing lung-selective medicines to treat respiratory disease, including YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Its revefenacin is a long-acting muscarinic antagonist (LAMA). Its programs also include Nezulcitinib, Ampreloxetine (TD-9855), Izencitinib, TD-5202 and TD-8236.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Theravance Biopharma Inc revenues decreased 23% to $55.3M. Net loss decreased 28% to $199.4M. Revenues reflect U.S. segment decrease of 21% to $55.3M, Europe segment decrease of 98% to $38K. Lower net loss reflects Research and development - bal decrease of 27% to $166.6M (expense), Selling, general and administrative -bal decrease of 55% to $31M (expense).
| Industry: | Pharmaceuticals (NEC) |
Ugland House, South Church Street
GEORGE TOWN
GRAND CAYMAN KY1-1104
KY
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com